Alnylam Pharmaceuticals
ALNY
#606
Rank
NZ$57.19 B
Marketcap
$443.42
Share price
-1.54%
Change (1 day)
58.09%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company